Candriam S.C.A. Raises Position in Xylem Inc. (NYSE:XYL)

Candriam S.C.A. increased its holdings in Xylem Inc. (NYSE:XYL) by 23.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 668,684 shares of the industrial products company’s stock after buying an additional 127,651 shares during the period. Candriam S.C.A. owned 0.28% of Xylem worth $77,581,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Farther Finance Advisors LLC raised its position in shares of Xylem by 6.6% in the third quarter. Farther Finance Advisors LLC now owns 1,412 shares of the industrial products company’s stock worth $191,000 after buying an additional 87 shares in the last quarter. Clear Creek Financial Management LLC raised its position in shares of Xylem by 4.3% in the fourth quarter. Clear Creek Financial Management LLC now owns 2,315 shares of the industrial products company’s stock worth $269,000 after buying an additional 96 shares in the last quarter. Bleakley Financial Group LLC raised its position in shares of Xylem by 2.3% in the fourth quarter. Bleakley Financial Group LLC now owns 4,359 shares of the industrial products company’s stock worth $506,000 after buying an additional 96 shares in the last quarter. U.S. Capital Wealth Advisors LLC raised its position in Xylem by 1.3% during the fourth quarter. U.S. Capital Wealth Advisors LLC now owns 7,868 shares of the industrial products company’s stock valued at $913,000 after purchasing an additional 98 shares in the last quarter. Finally, Mcrae Capital Management Inc. raised its position in Xylem by 2.9% during the fourth quarter. Mcrae Capital Management Inc. now owns 3,575 shares of the industrial products company’s stock valued at $415,000 after purchasing an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 1.9 %

NYSE XYL opened at $129.74 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.76 and a quick ratio of 1.33. The stock has a market capitalization of $31.52 billion, a PE ratio of 35.45, a PEG ratio of 2.33 and a beta of 1.07. Xylem Inc. has a 1 year low of $113.26 and a 1 year high of $146.08. The business’s 50-day moving average is $123.29 and its 200 day moving average is $127.10.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.06. The company had revenue of $2.30 billion for the quarter, compared to analysts’ expectations of $2.18 billion. Xylem had a return on equity of 9.96% and a net margin of 10.40%. Xylem’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the firm earned $0.99 earnings per share. Sell-side analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Shareholders of record on Tuesday, February 18th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.23%. This is a boost from Xylem’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend is Tuesday, February 18th. Xylem’s payout ratio is presently 43.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on XYL shares. Citigroup downgraded Xylem from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 5th. TD Cowen lowered their price target on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a research report on Wednesday, November 6th. Wolfe Research restated a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Stifel Nicolaus decreased their price objective on Xylem from $166.00 to $150.00 and set a “buy” rating on the stock in a report on Friday, January 24th. Finally, Robert W. Baird lifted their price objective on Xylem from $139.00 to $148.00 and gave the stock an “outperform” rating in a report on Wednesday, February 5th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and a consensus price target of $149.90.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.